Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glycyrrhiza protein is a proteinaceous extract derived from the *Glycyrrhiza* (licorice) plant. In preclinical research, it has been utilized both as a standalone agent and as a structural component in self-assembled nanoparticles (such as glycyrrhiza protein-paeoniflorin nanoparticles) for the treatment of rheumatoid arthritis. Its therapeutic effects are attributed to the modulation of glycerophospholipid metabolism and the downregulation of the PI3K/AKT/mTOR-NLRP3 signaling pathway. This leads to a reduction in synovial inflammation and the inhibition of pyroptosis-related factors like Caspase-1 and Gasdermin D.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycyrrhiza protein.